Hype check: Harry’s Razors

Hype check: Harry’s Razors

SOCIAL MEDIA SAVVY MARKETING AND GREAT PRODUCT DESIGN DREW ME IN, BUT THE SHAVE EXPERIENCE LEFT ME WANTING. If you spend any amount of time on Facebook, or listen to any podcast even remotely technology oriented, than you most likely have seen an ad for Harry’s, an upstart razor and shaving product company. Harry’s pitch is pretty simple. “Should an 8-Pack of Quality Blades Really Cost 32 Dollars? Harry’s, Worth the Switch.” The cost of razors is outrageous, and I cringe every time I have to buy them. I’ve resorted…

5 Key Takeaways From the FDA’s Draft Guidance On Correcting Independent Third-Party Misinformation

5 Key Takeaways From the FDA’s Draft Guidance On Correcting Independent Third-Party Misinformation

  Yesterday the FDA released not one, but two documents providing draft guidance on the utilization of particular aspects of social media, entitled Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation about prescription Drugs and Medical Devices, which is the focus of this post. The other, Internet/Social Media Limitations – Presenting Risk And Benefit Information for Prescription Drugs and Medical Devices, can be read about in another posting. In keeping with the tradition of most of these releases, these guidelines are drafts and may change over time, but in reading them there are 5…

Who Responds To The Responders?

Who Responds To The Responders?

As I thought it might, my last post about social media stirred quite a bit of discussion. As such, I thought it would be useful to perhaps dedicate another post as a means of both clarifying my position, and providing some counter-points to the various responses that have been generated around the web. To recap, my original post wasn’t meant to suggest that pharma should completely abandon social media, but rather that the interest in social engagements is over-calibrated when weighed against the potential business impact for a given brand….

Is It Time For Pharma To Give Up The Social Media Ghost?

Is It Time For Pharma To Give Up The Social Media Ghost?

Social media has been a big focus for pharma marketers for a while now. By my count, at least 30-45% of ePharma’s agenda from the 2014 NY conference was focused on the subject, and there is a whole cottage industry of other conferences specifically for social media fin the pharma industry. If you spend any time following pharma folks on Twitter, you can find tons of tweets on the subject and create whole feeds for hashtags like #socpharm, #hcsm, #pharmsm, etc. I say it’s time to move on. You read…